IDO1 and neoplasm: By converting TRP to KYN, MSCs-sourced IDO induces low TRP levels, activates GCN2 kinase and suppresses PKB/mTOR signaling in tumor-infiltrating Tregs, preventing their trans-differentiation in anti-tumorigenic Th17-like cells [7].